The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study.
暂无分享,去创建一个
B. Horne | H. May | R. Pearson | Jeffrey L. Anderson | R. Wolfert | J. Muhlestein | R. Lanman | F. Lavasani | J. Jensen | H. D. Yannicelli | Jeffrey L. Anderson | H. D. Yannicelli